fukuyama congenital muscular dystrophy fcmd rare autosomal recessive form muscular dystrophy weakness breakdown muscular tissue mainly described japan also identified turkish ashkenazi jewish fifteen cases first described dr yukio fcmd mainly affects brain eyes muscles particular disorder affects development skeletal muscles leading weakness deformed appearances brain development blunted affecting cognitive functioning well social disorder linked mutations gene coding protein fukutin fcmd gene fukuyama congenital muscular dystrophy second prevalent form muscular dystrophy japan one every people japan heterozygous carriermedical citation needed terms signssymptoms fukuyama congenital muscular dystrophy characterized decrease skeletal muscle tone well impairment brain eye development initial symptoms fcmd present early infancy decreased ability feed marked differences facial appearance occur due decreased muscle tone characteristics fukuyama congenital muscular dystrophy also affects nervous system various associated parts fcmd affects normal development brain producing broadly smooth bumpy shaped cortex named cobblestone lissencephaly well various malformations notably micropolygyria children also experience delayed myelination cause fukuyama congenital muscular dystrophy rooted fktn gene located human chromosome encoding protein fukutin mutations gene therefore fukutin protein cause disease inherited autosomal recessive means defective gene responsible disorder located autosome chromosome autosome two copies defective gene one inherited parent required order born disorder parents individual autosomal recessive disorder carry one copy defective gene usually experience signs symptoms two mutations identified first common sva retrotransposal insertion region second deepintronic point mutation second mutation found date presence first mechanism subtype muscular dystrophy consists mutation fktn gene results malformed fukutin protein thought fukutin modifies alphadystroglycan protein important anchoring cells certain molecules specifically including proteins alphadystroglycan skeletal muscles helps prevent breakdown muscle fibers stabilization protection alphadystroglycan also helps brain development assisting migration neurons frequently fktn mutated way creates shortage fukutin cell turn creates problems formation alphadystroglycan leading less stabilization muscle use destabilized muscle fibers time causes break gradual decline muscle tone atrophy muscle fibers occurs decline cerebral fukutin causes neuronal cells continue moving beyond intended destination additionally oxidative stress effect astrocytes well neurons fukutin terms diagnosis fukuyama congenital muscular dystrophy serum creatine kinase concentration muscle biopsies obtained help determine individual fmcd fktn molecular genetic testing used determine mutation fktn gene serum creatine kinase concentration muscle biopsies andor mri imaging presented abnormalities indicative fcmd presence symptoms indicates fukuyama congenital muscular dystrophy available genetic test currently subtype muscular dystrophy cure definitive treatment treatment offers preventative tactics delay muscle breakdown increase life expectancy stretching physical therapy increase mobility treatment also includes correcting skeletal abnormalities orthopedic surgery orthopedic techniques antiepileptic medication administered help prevent seizures ace inhibitors beta blockers help treat heart conditions respiratory assistance likely needed point affected fukuyama congenital muscular dystrophy poor prognosis children fcmd reach maximum mobility sitting upright sliding due compounded effects continually worsening heart problems impaired mental development problems swallowing additional complications children fcmd rarely live adolescence disorder proves fatal age httpsenwikipediaorgwikifukuyamacongenitalmusculardystrophy